Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients
Vanrenterghem, Y.; Waer, M.; De Keyser, P.; Roels, L.; Michielsen, P.
Transplantation Proceedings 20(3 Suppl 3: 615-617
1988
ISSN/ISBN: 0041-1345 PMID: 3291296 Document Number: 320522
Document emailed within 1 workday
Related Documents
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285Brynger, H.; Persson, H.; Flatmark, A.; Albrechtsen, D.; Frödin, L.; Tufvesson, G.; Gäbel, H.; Weibull, H.; Möller, E.; Lundgren, G. 1988: No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience Transplantation Proceedings 20(3 Suppl 3: 261-263
Busnach, G.; Stragliotto, E.; Minetti, E.; Perego, A.; Brando, B.; Broggi, M.L.; Civati, G. 1998: Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study Journal of Nephrology 11(2): 87-93
Thiel, G.; Mihatsch, M.; Landmann, J.; Hermle, M.; Brunner, F.P.; Harder, F. 1985: Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive? Transplantation Proceedings 17(4 Suppl 1: 169-178
Jakobsen, A.; Flatmark, A.; Lundgren, G.; Solheim, B.; Groth, C.G. 1981: A controlled trial with AHLG Behring: lack of effect on cadaveric renal graft survival Scandinavian Journal of Urology and Nephrology. Supplementum 64: 205-212
Driscoll, D.F.; Pinson, C.W.; Jenkins, R.L.; Bistrian, B.R. 1989: Potential protective effects of furosemide against early cyclosporine-induced renal injury in hepatic transplant recipients Transplantation Proceedings 21(3): 3549-3550
Kumar, M.S.; Samhan, M.; John, P.; al-Adnani, M.S.; Abouna, G.M. 1989: Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation? Transplantation Proceedings 21(1 Part 2): 1552-1553
Landsberg, D.; Rae, A.; Chiu, A.; Werb, R.; Taylor, P.; Chan-Yan, C.; Manson, A.D. 1989: The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation Transplantation Proceedings 21(2): 3323-3324
Zanker, B.; Barth, C.; Menges, A.V.; Lammerding, P.; Stachowski, J.; Baldamus, C.A. 1995: Expression of the multidrug resistance gene MDR-1 in peripheral blood mononuclear cells from cyclosporine-treated renal transplant recipients rejecting their graft Transplantation Proceedings 27(1): 925-926
Chomette, G.; Auriol, M.; Beaufils, H.; Rottemburg, J.; Cabrol, C. 1986: Morphology of cyclosporine nephrotoxicity in human heart transplant recipients Journal of Heart Transplantation 5(4): 273-278
Karim, M.S.; Wood, R.F. 1988: Ameliorating cyclosporine nephrotoxicity with intravenous protective agents Transplantation Proceedings 20(3 Suppl 3: 239-243
Kojima, R.; Suzuki, Y. 1984: Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects. (2). Protective effect of latamoxef against gentamicin nephrotoxicity Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 84(5): 463-469
Yoshimura, N.; Kahan, B.D.; Oka, T. 1991: The in vivo effect of cyclosporine on interleukin-6 gene expression in renal transplant recipients Transplantation Proceedings 23(1 Pt 2): 958-960
Spielberger, M.; Aigner, F.; Schmid, T.; Bösmüller, C.; Königsrainer, A.; Margreiter, R. 1988: Long-term results of cadaveric renal transplantation after conversion from cyclosporine to azathioprine: a controlled randomized trial Transplantation Proceedings 20(3 Suppl 3): 169-170
Canafax, D.M.; Simmons, R.L.; Sutherland, D.E.; Fryd, D.S.; Strand, M.H.; Ascher, N.L.; Payne, W.D.; Najarian, J.S. 1986: Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine Transplantation Proceedings 18(2 Suppl 1): 192-196
Kelly, J.J.; Walker, R.G.; d'Apice, A.J.; Kincaid-Smith, P. 1990: A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results Transplantation Proceedings 22(5): 2127-2128
Wang, M.; Qu, X.; Stepkowski, S.M.; Chou, T.C.; Kahan, B.D. 1996: Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus Transplantation 61(3): 458-464
Salomon, D.R. 1991: An alternative view minimizing the significance of cyclosporine nephrotoxicity and in favor of enhanced immunosuppression for long-term kidney transplant recipients Transplantation Proceedings 23(4): 2115-2118
Kahan, B.D.; Julian, B.A.; Pescovitz, M.D.; Vanrenterghem, Y.; Neylan, J. 1999: Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group Transplantation 68(10): 1526-1532
Stahl, R.A.; Kanz, L.; Maier, B.; Schollmeyer, P. 1986: Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cyclosporine a associated side effect Clinical Nephrology 25(5): 245-248